Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Prediction of hot flushes in women taking tamoxifen for breast cancer prevention

Michael Hale - Queen Mary University, London, UK
Prediction of hot flushes in women taking tamoxifen for breast cancer prevention ( Michael Hale - Queen Mary University, London, UK )
5 Oct 2020

The impact of COVID-19 on breast cancer screening, treatment, research and meetings

Prof David Cameron - Representative EBC Council
The impact of COVID-19 on breast cancer screening, treatment, research and meetings ( Prof David Cameron - Representative EBC Council )
5 Oct 2020

Improved decision making for older women with early breast cancer

Prof Lynda Wyld - University of Sheffield, Sheffield, UK
Improved decision making for older women with early breast cancer ( Prof Lynda Wyld - University of Sheffield, Sheffield, UK )
2 Oct 2020

MINDACT: 70-gene signature test as guidance for breast cancer treatment

Josephine Lopes Cardozo - Netherlands Cancer Institute, Amsterdam, The Netherlands
MINDACT: 70-gene signature test as guidance for breast cancer treatment ( Josephine Lopes Cardozo - Netherlands Cancer Institute, Amsterdam, The Netherlands )
1 Oct 2020

Management of infection risk to myeloma patients during the COVID pandemic

Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria
Management of infection risk to myeloma patients during the COVID pandemic ( Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria )
1 Oct 2020

Lenalidomide combination for multiple myeloma

Prof Xavier Leleu - Hôpital La Mileterie CHU, Poitiers, France
Lenalidomide combination for multiple myeloma ( Prof Xavier Leleu - Hôpital La Mileterie CHU, Poitiers, France )
1 Oct 2020

OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negative advanced breast cancer

Prof Fabrice André - Institut Gustave Roussy, Paris, France
OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negative advanced breast cancer ( Prof Fabrice André - Institut Gustave Roussy, Paris, France )
29 Sep 2020

ESMO 2020 melanoma roundup

Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
ESMO 2020 melanoma roundup ( Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany )
28 Sep 2020

OncoAlert and ecancer weekly roundup for September 20 - 26, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for September 20 - 26, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
28 Sep 2020

Nivolumab for oesophageal cancer following chemoradiation therapy

Dr Ronan Kelly - Charles A. Sammons Cancer Center, Dallas, USA
Nivolumab for oesophageal cancer following chemoradiation therapy ( Dr Ronan Kelly - Charles A. Sammons Cancer Center, Dallas, USA )
25 Sep 2020

PROFound trial and other recent updates in prostate cancer

Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
PROFound trial and other recent updates in prostate cancer ( Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Sep 2020

Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma

Dr Noemí Puig - Hospital Universitario de Salamanca, Salamanca, Spain
Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma ( Dr Noemí Puig - Hospital Universitario de Salamanca, Salamanca, Spain )
25 Sep 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation